Company Filing History:
Years Active: 1996-2008
Title: Innovations and Contributions of Inventor Peter A Ward
Introduction
Peter A Ward is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of sepsis. With a total of 6 patents to his name, his work has the potential to impact patient care and treatment protocols.
Latest Patents
Among his latest patents, one focuses on "Compositions and methods for the diagnosis and treatment of sepsis." This invention relates to methods and compositions that aid in diagnosing and treating sepsis. It also provides methods for offering a prognosis to patients suffering from this condition. Specifically, it addresses the detection of C5aR expression and correlates the levels of C5aR expression with prognosis in sepsis. Another significant patent is titled "Compositions and methods for the treatment of sepsis." This invention discusses compositions and methods aimed at preventing and treating blood-borne and toxin-mediated diseases. It particularly emphasizes the use of anti-C5a antibodies for the prevention and treatment of sepsis in both humans and other animals. Additionally, it outlines methods for generating anti-C5a antibodies using C-terminal truncated C5a peptides.
Career Highlights
Peter A Ward has had a distinguished career, working with reputable institutions such as the University of Michigan and Shiseido Company, Limited. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues, including Markus Huber-Lang and Vidya Sarma. These collaborations have further enriched his research and development efforts.
Conclusion
Peter A Ward's contributions to the field of medical science, particularly in the area of sepsis treatment and diagnosis, highlight his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing medical knowledge and practices.